Autoimmune disease diagnostic panel testing
Customize your policy alerts
Sign up for AmeriHealth Caritas Policy CCP.1562 alerts
Get alerted when Policy CCP.1562 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage for blood-based multianalyte and proprietary algorithm autoimmune diagnostic panels (including AVISE-type tests and cell-bound complement activation product panels) for diagnosis, differentiation, prognosis, risk stratification, or management of systemic autoimmune diseases such as systemic lupus erythematosus (SLE). It affects AmeriHealth Caritas members and their providers seeking coverage for these tests.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.